Meikang biology: it plans to continue to use idle fund-raising of no more than 100 million yuan for cash management
It is announced that Meikang will not use more than 100 million yuan of idle cash for fund-raising management.
This text is a result of machine translation.
In-depth
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 05, 2023 07:33 PM
Briefing Sep 18, 2023 07:40 PM
· Technology
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Briefing Feb 23, 2023 10:59 AM
· Technology
Power Device Company Maplesemi Completes Series A+ Financing Round
Briefing Feb 23, 2023 10:53 AM
· Technology
Acoustic Technology Company Audfly Completes Series B Financing Round
Briefing Feb 23, 2023 10:45 AM
· Technology
Wicue Raised CNY 200 Mn in Series C+ Financing Round
Briefing Feb 23, 2023 10:36 AM
· Technology
Intelligent Industrial Drone and UAV Systems Developer I-KINGTEC Closed A Series C+ Financing Round
Briefing Feb 23, 2023 10:34 AM
· Technology
Em-Data Technology Completed Strategic Financing Round
Briefing Feb 21, 2023 11:10 AM
· Healthcare
We-Linking Raised Over CNY 10 Mn in Angel Round
See more
Read next
Insight
In-depth
Insight
In-depth